Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

about

Emerging antibody-drug conjugates for treating lymphoid malignancies.

P2860

Q38632313-B9CD2742-6C5D-4B35-8866-49F0BCD14559

P2860

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

Item

http://www.wikidata.org/entity/Q39091822

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

@en

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

@nl

type

Item

label

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

@en

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

@nl

prefLabel

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

@en

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

@nl

P1476

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

@en

P2093

Amitkumar Mehta

http://www.w3.org/2001/XMLSchema#string

Lakshminarayanan Nandagopal

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of lenalidomide in hematological malignancies

Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain

Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas

Obinutuzumab in hematologic malignancies: lessons learned to date

Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Cancer statistics, 2015

Alternative molecular formats and therapeutic applications for bispecific antibodies

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study

Bispecific T-cell engaging antibodies for cancer therapy

P304

259-273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17474086.2017.1283214

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28094575

http://www.w3.org/2001/XMLSchema#string

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

about

P2860

P2860

Treatment approaches of hard-to-treat non-Hodgkin lymphomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698